Boehringer Ingelheim

Boehringer Ingelheim

Boehringer Ingelheim - researching, developing, manufacturing and marketing of pharmaceuticals.

HQ location
Ingelheim am Rhein, Germany
Website
boehringer-ingelheim.com
Launch date
Employees
10001+ people
Jobs
View job openings
Recent deals
Corporate Venture Fund
Boehringer Ingelheim Venture Fund
https://twitter.com/boehringerhttps://www.facebook.com/boehringeringelheimhttps://www.linkedin.com/company/boehringer-ingelheim
  • Healthcare
    • Edit
DateInvestorsAmountRound

N/A

Spinout
Total Funding000k
University of Zürich
University of Zürich

Related Content

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo
Investments analysisEdit
By Country
United States 6Switzerland 4Canada 3Austria 2China 2Belgium 2India 1Denmark 1Kenya 1Ghana 1Germany 1
By Industry
Health 23Food 1
By Round
ACQUISITION 11EARLY VC 4POST IPO EQUITY 3SERIES A 2GROWTH EQUITY VC 1NOT SET 1DEBT 1SERIES C 1SUPPORT PROGRAM 1GRANT 1
    • Edit
MabVax Therapeutics
MabVax Therapeutics
exited
Actimis Pharmaceuticals
Actimis Pharmaceuticals
ACQUISITION by Boehringer Ingelheim Jun 2008
Lupin
Lupin
Amal Therapeutics
Amal Therapeutics
ACQUISITION by Boehringer Ingelheim Jul 2019
NBE-Therapeutics
NBE-Therapeutics
ACQUISITION by Boehringer Ingelheim Dec 2020
T3 Pharmaceuticals
T3 Pharmaceuticals
ACQUISITION by Boehringer Ingelheim Nov 2023
Saniona
Saniona
Vira Therapeutics
Vira Therapeutics
ACQUISITION by Boehringer Ingelheim Sep 2018
Ruipeng Pet Medical Group
Ruipeng Pet Medical Group
Phenomic AI
Phenomic AI
View 55 more